1. Home
  2. CYTK vs PLNT Comparison

CYTK vs PLNT Comparison

Compare CYTK & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • PLNT
  • Stock Information
  • Founded
  • CYTK 1997
  • PLNT 1992
  • Country
  • CYTK United States
  • PLNT United States
  • Employees
  • CYTK N/A
  • PLNT N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • PLNT Hotels/Resorts
  • Sector
  • CYTK Health Care
  • PLNT Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • PLNT Nasdaq
  • Market Cap
  • CYTK 6.0B
  • PLNT 8.3B
  • IPO Year
  • CYTK 2004
  • PLNT 2015
  • Fundamental
  • Price
  • CYTK $48.87
  • PLNT $99.30
  • Analyst Decision
  • CYTK Buy
  • PLNT Buy
  • Analyst Count
  • CYTK 16
  • PLNT 17
  • Target Price
  • CYTK $84.07
  • PLNT $91.53
  • AVG Volume (30 Days)
  • CYTK 1.1M
  • PLNT 883.2K
  • Earning Date
  • CYTK 11-06-2024
  • PLNT 02-20-2025
  • Dividend Yield
  • CYTK N/A
  • PLNT N/A
  • EPS Growth
  • CYTK N/A
  • PLNT 15.44
  • EPS
  • CYTK N/A
  • PLNT 1.86
  • Revenue
  • CYTK $3,219,000.00
  • PLNT $1,049,214,000.00
  • Revenue This Year
  • CYTK N/A
  • PLNT $18.54
  • Revenue Next Year
  • CYTK $795.25
  • PLNT $9.52
  • P/E Ratio
  • CYTK N/A
  • PLNT $53.36
  • Revenue Growth
  • CYTK N/A
  • PLNT 4.90
  • 52 Week Low
  • CYTK $43.21
  • PLNT $54.35
  • 52 Week High
  • CYTK $110.25
  • PLNT $102.90
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.62
  • PLNT 54.94
  • Support Level
  • CYTK $45.66
  • PLNT $96.93
  • Resistance Level
  • CYTK $49.40
  • PLNT $102.90
  • Average True Range (ATR)
  • CYTK 1.71
  • PLNT 2.36
  • MACD
  • CYTK -0.20
  • PLNT -0.75
  • Stochastic Oscillator
  • CYTK 50.79
  • PLNT 39.70

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

Share on Social Networks: